Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Quick Stats
Feb 02, 202641.8
AI Score
HOLD4.1
Volume Ratio
Mar 12, 2026
Next Earnings
16
+ve Days (30d)
13
-ve Days (30d)
PHAR Stock Summary
Last updated Feb 02, 2026
PHAR is currently trading at $16.975, positioned above its 200-day moving average of $13.52, indicating a long-term uptrend. The stock has a 52-week range of $7.5018 to $21.34.
Technical Analysis: The 50-day moving average stands at $17.69, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.357, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.163, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates PHAR at 41.8/100 with a HOLD recommendation.
PHAR (Pharming Group N.V. ADS, each representing 10 ordinary shares) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 41.357 |
| CMF (20) | 0.163 |
| ROC (10) | -7.945 |
| ADX (14) | 32.064 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.661 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -86.607 |
| MFI (14) | 44.856 |
PHAR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PHAR Price vs Max Options Open Interest
PHAR Max Change In Options Open Interest
PHAR Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAR Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAR Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAR Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Pharming Group N.V. ADS, each representing 10 ordinary shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
PHAR Moving Averages Analysis
Pharming Group N.V. ADS, each representing 10 ordinary shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
PHAR (Pharming Group N.V. ADS, each representing 10 ordinary shares) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 19.54 |
| 20 | 18.75 |
| 30 | 18.23 |
| 50 | 17.69 |
| 100 | 16.15 |
| 200 | 13.52 |
PHAR Fundamental Analysis
| P/E (Forward) | 54.6448 |
| P/E (Trailing) | 0 |
| Market Cap ($) | 1.4 billion |
| Earnings/Share ($) | 0 |
| Net Proft Margin (%) | 0.0011 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.021 |
| EPS Estimate Next Year ($) | 0.0635 |
| WallStreet Target Price ($) | 31 |
| Most Recent Quarter |